Skip to main content

Table 5 Disease activity at baseline and 6 months as measured on the patient subjective measure of disease activity and disease activity indices

From: Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial

 

+CBT

SC

 

n (%)

 

Baseline

6 months

12 months

Baseline

6 months

12 months

n = 90

n = 51

n = 42

n = 84

n = 65

n = 64

IBD control

Very well

27 (30)

18 (35)

14 (33)

18 (21.4)

17 (26.1)

27 (42)

 

Reasonably

54 (60)

26 (50)

18 (43)

56 (66.7)

35 (53.8)

30 (47)

 

Not well

7 (8)

3 (6)

5 (12)

6 (7.1)

7 (10.8)

3 (5)

CDAI

Active >150

15 (17)

8 (16)

5 (12)

11 (13.1)

8 (12.3)

8 (12)

SCCAI#

Active >3

8 (9)

8 (16)

6 (14)

10 (11.9)

14 (21.5)

9 (14)

  

Mean (SD)

 

CDAI

 

110.8 (72.5)

91.3 (90.3)

84.1 (95.3)

87.4 (104.8)

83.2 (92.2)

88.4 (105.9)

SCCAI

 

3.4 (1.4)

3.5 (1.8)

2.9 (1.6)

3.2 (1.3)

3.7 (1.6)

3.5 (2.5)

  1. #Contrary to the commonly used cut off point of >2, in this study SCCAI was considered normal between 0 and 3 as only few participants (all considered by doctors to be in remission) had a score below 3 with subscore of 0 for rectal bleeding.